Julianne Averill is interim CFO at Cartography Biosciences and Senior Director with Danforth Advisors.  A senior finance and strategy executive with more than 20 years of leadership experience driving results and accelerating growth in the biotech and digital health fields, Julianne is known for her innovative, visionary, and effective leadership. She advises high-growth public and private life science companies on a wide range of finance and business transformation issues, including identifying effective capital allocation and fundraising strategies; managing U.S. and international product launches; and establishing supply chain and commercial channels to support growth and scale.

Julianne has been praised and won awards for her ability to make complex topics accessible in areas as diverse as finance, business operations, digital health, IPO readiness, SOX compliance, and healthcare advocacy. Her breadth and depth of product and technical experience spans across therapeutics, pharmaceuticals, medical devices, digital therapeutics, AI, and machine learning. She leverages her experience and expertise to help devise business growth and funding strategies for start-up, pre-IPO, post-IPO and public companies, including successfully closing over $10 billion in fundraising and M&A initiatives for companies that are bringing life-saving technologies to market. She brings a unique perspective and a depth of knowledge to add value to founders, investors, and boards in the biotech space.

Julianne is a Certified Public Accountant (CPA) in the State of California and is a Society of Human Resources Certified Professional (SHRM-CP). She holds a B.S. in Business Administration and an M.S. in Accountancy from California State University, Fresno and has received a certificate in Business/Data Analytics from Harvard University. In her spare time, she serves in various leadership and board roles for international nonprofits and local city organizations that support leadership development and community impact.